Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Change in Inventory (2024 - 2025)

Beta Bionics' Change in Inventory history spans 2 years, with the latest figure at $2.2 million for Q4 2025.

  • For Q4 2025, Change in Inventory rose 82.22% year-over-year to $2.2 million; the TTM value through Dec 2025 reached $9.9 million, down 13.63%, while the annual FY2025 figure was $9.9 million, 13.63% down from the prior year.
  • Change in Inventory for Q4 2025 was $2.2 million at Beta Bionics, down from $3.3 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $3.9 million in Q3 2024 and bottomed at $1.2 million in Q4 2024.